Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study

Background: Vitiligo is a chronic acquired disorder characterized by the depigmented macules. There are many treatment options, but the response is variable and unsatisfactory. Topical 5-fluorouracil used in many dermatological diseases but, this is the first study to date that use 0.5% concentratio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sara Galal, Moshiraly Ali, Fatma Elzeiny
Formato: article
Lenguaje:EN
Publicado: Al-Azhar University, Faculty of Medicine (Damietta) 2021
Materias:
Acceso en línea:https://doaj.org/article/11f0ba5ad10643589c16b9384fb5f977
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11f0ba5ad10643589c16b9384fb5f977
record_format dspace
spelling oai:doaj.org-article:11f0ba5ad10643589c16b9384fb5f9772021-12-02T19:33:14ZEvaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study2636-41742682-378010.21608/ijma.2021.89242.1347https://doaj.org/article/11f0ba5ad10643589c16b9384fb5f9772021-10-01T00:00:00Zhttps://ijma.journals.ekb.eg/article_193556_6106a3e936814afda52fe162013069db.pdfhttps://doaj.org/toc/2636-4174https://doaj.org/toc/2682-3780Background: Vitiligo is a chronic acquired disorder characterized by the depigmented macules. There are many treatment options, but the response is variable and unsatisfactory. Topical 5-fluorouracil used in many dermatological diseases but, this is the first study to date that use 0.5% concentration in vitiligo treatment.The Aim of The Work: This study evaluates efficacy and safety topical 5-fluorouracil in 0.5% concentration in treatment of resistant vitiligo either alone or after microneedling.Subject and Methods: 30 patients with resistant vitiligo were enrolled into the study; we studied only 2 patches in every patient. The first patch treated with one session of microneedling followed by topical 5-fluorouracil 0.5% once daily for 2 weeks. The second patch treated with topical 5-fluorouracil 0.5% only for 2 weeks, then follow up of both patches for 3 months.Results: Excellent response achieved in 46.7% of the patches treated with microneedling followed by topical 5-fluorouracil 0.5%, while only in 23.3% of the patches treated with topical 5-fluorouracil 0.5% alone. There was no significant difference between both groups regarding response, despite this the degree of improvement was higher in combined treatment.Conclusion: Topical 5-fluorouracil 0.5% is an effective and safe in treatment of resistant vitiligo and combined therapy increases the efficacy.Sara GalalMoshiraly AliFatma ElzeinyAl-Azhar University, Faculty of Medicine (Damietta)article5-fluorouracil 0.5%microneedlingpigmentationvitiligoMedicine (General)R5-920ENInternational Journal of Medical Arts, Vol 3, Iss 4, Pp 1803-1810 (2021)
institution DOAJ
collection DOAJ
language EN
topic 5-fluorouracil 0.5%
microneedling
pigmentation
vitiligo
Medicine (General)
R5-920
spellingShingle 5-fluorouracil 0.5%
microneedling
pigmentation
vitiligo
Medicine (General)
R5-920
Sara Galal
Moshiraly Ali
Fatma Elzeiny
Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study
description Background: Vitiligo is a chronic acquired disorder characterized by the depigmented macules. There are many treatment options, but the response is variable and unsatisfactory. Topical 5-fluorouracil used in many dermatological diseases but, this is the first study to date that use 0.5% concentration in vitiligo treatment.The Aim of The Work: This study evaluates efficacy and safety topical 5-fluorouracil in 0.5% concentration in treatment of resistant vitiligo either alone or after microneedling.Subject and Methods: 30 patients with resistant vitiligo were enrolled into the study; we studied only 2 patches in every patient. The first patch treated with one session of microneedling followed by topical 5-fluorouracil 0.5% once daily for 2 weeks. The second patch treated with topical 5-fluorouracil 0.5% only for 2 weeks, then follow up of both patches for 3 months.Results: Excellent response achieved in 46.7% of the patches treated with microneedling followed by topical 5-fluorouracil 0.5%, while only in 23.3% of the patches treated with topical 5-fluorouracil 0.5% alone. There was no significant difference between both groups regarding response, despite this the degree of improvement was higher in combined treatment.Conclusion: Topical 5-fluorouracil 0.5% is an effective and safe in treatment of resistant vitiligo and combined therapy increases the efficacy.
format article
author Sara Galal
Moshiraly Ali
Fatma Elzeiny
author_facet Sara Galal
Moshiraly Ali
Fatma Elzeiny
author_sort Sara Galal
title Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study
title_short Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study
title_full Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study
title_fullStr Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study
title_full_unstemmed Evaluation of Efficacy and Safety Topical 5-Fluorouracil 0.5% in Treatment of Resistant Vitiligo [Alone or After Microneedling]; A pilot Study
title_sort evaluation of efficacy and safety topical 5-fluorouracil 0.5% in treatment of resistant vitiligo [alone or after microneedling]; a pilot study
publisher Al-Azhar University, Faculty of Medicine (Damietta)
publishDate 2021
url https://doaj.org/article/11f0ba5ad10643589c16b9384fb5f977
work_keys_str_mv AT saragalal evaluationofefficacyandsafetytopical5fluorouracil05intreatmentofresistantvitiligoaloneoraftermicroneedlingapilotstudy
AT moshiralyali evaluationofefficacyandsafetytopical5fluorouracil05intreatmentofresistantvitiligoaloneoraftermicroneedlingapilotstudy
AT fatmaelzeiny evaluationofefficacyandsafetytopical5fluorouracil05intreatmentofresistantvitiligoaloneoraftermicroneedlingapilotstudy
_version_ 1718376364550127616